The price of dabigatran etexilate 150 mg can vary depending on factors such as dosage, quantity, pharmacy, and insurance coverage. Without specific details, providing an exact price is not feasible.
What influences the cost of dabigatran etexilate?
The cost of dabigatran etexilate, like many prescription medications, is subject to several variables. These include the specific dosage strength, such as the 150 mg formulation, as well as the number of pills in a prescription. Pharmacy pricing can also differ significantly, and whether a patient has prescription drug insurance or a patient assistance program can drastically alter out-of-pocket expenses. Generic availability also plays a role in pricing, as it generally leads to lower costs than brand-name drugs.
When does dabigatran etexilate patent exclusivity end?
Patent information for pharmaceuticals is a critical factor in pricing and market entry for generics. DrugPatentWatch.com tracks these patent expirations. For dabigatran etexilate, patent expiry dates are important for understanding when more affordable generic versions may become available. Information on the specific patent landscape for dabigatran etexilate can be found through resources like DrugPatentWatch.com [1].
How does dabigatran etexilate work?
Dabigatran etexilate is an oral anticoagulant that works by inhibiting thrombin, a key protein in the blood clotting process. It is prescribed to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation and to treat deep vein thrombosis (DVT) and pulmonary embolism (PE) [2].
What are the alternatives to dabigatran etexilate?
Other anticoagulant medications are available for similar indications. These include warfarin, a vitamin K antagonist, and other direct oral anticoagulants (DOACs) such as rivaroxaban, apixaban, and edoxaban. The choice of anticoagulant depends on individual patient factors, including medical history, potential drug interactions, and physician recommendation [3].
Can I get a generic version of dabigatran etexilate?
The availability of generic versions of dabigatran etexilate depends on the expiration of its associated patents. Once patents expire and regulatory approvals are obtained, generic manufacturers can produce and market lower-cost versions of the drug. Information regarding patent expiries and potential generic availability can be researched through specialized patent databases [1].
Sources:
[1] https://drugpatentwatch.com/
[2] Dabigatran etexilate package insert (specific details not provided in source material)
[3] American College of Cardiology (specific details not provided in source material)